PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
CityMunch allows restaurants to catch potential customers through real time offer platforms. Allowing restaurants to attract customers specifically in the least busiest times of the day. CityMunch will use the funding to expand throughout the city.
days to go:
Expired
investment:
£174,582
Award-winning non-dairy luxury ice cream, which is also organic and vegan. Coconuts Naturally will be launching their range of 5 flavours in over 600 supermarkets across the UK from March 2019. after successfully achieving listings with Ocado, Morrison’s and Asda. The company differentiates itself from competitors by primarily using coconut cream and unrefined coconut sugar in their products. Coconuts Naturally have won seven Great Taste Awards and Peter Jones of Dragon's Den has claimed it the best free-from ice cream he has tasted.
The business is raising funds to increase brand awareness by entering international markets. Coconuts Naturally is stocked at 2 supermarkets in Dubai, as well as launching in Hong Kong soon and currently seeking product registration in Saudi Arabia. The company will be focusing on marketing campaigns via digital and in-store promotions. In addition, due to the upcoming supermarket launch, the business will also be increasing stock levels to meet consumer demand.
days to go:
Expired
investment:
£422,580
Rightangled is a healthcare technology company backed by NHS England & regulated by the Care Quality Commission (CQC). It began its journey as a platform that would enable the use of genetic information within the medical practice, in an accurate, streamlined, and affordable way. It gradually established itself as a healthcare provider for screening and diagnostic services. Its Heart DNA Test project, launched in 2017, is helping patients minimize their cardiac risks and enabling doctors to have a complete risk profile for their patients. The project was appreciated and received funding from NHS England. Its next project, Fitness DNA Test, tapped into the fitness and wellbeing markets. Recently, in the wake of the COVID-19 threat, the company has developed a home-based throat swab test to detect the viral infection, by testing viral load presented in its nucleic acid material within (RNA). For its efforts, Rightangled has been featured on CNN, Sky News, LBC radio, Sky News radio, and Newsweek. With the investment, the company aims to release a mobile application by the end of 2020, and develop an AI system to give instant tailored health, diet, and fitness advice to its users based on the data gathered from patient-doctor interactions and patient responses.
days to go:
Expired
investment:
£522,689
Brands reunited are looking to disrupt the modern craft beer market. Their sales are over £400k and are growing 100% year on year. They have two brands that are already in Watneys and Home Ales. The funding will be spent on building their brand and the team.
days to go:
Expired
investment:
£255,000
Urban is a wellness app that allows customers to book massages, beauty treatments, personal training and more at the customer's doorstep in 60 minutes. The company's practitioners are already operating in London, Paris, Manchester and Birmingham covering all aspects of wellness, from massage to mindfulness and beyond. Urban has delivered over 650,000 appointments till date, witnessed £43 million in cumulative sales value since August 2018, onboarded 3,800 partner practitioners, and saw 7,300+ reviews on Apple app store with an average rating of 4.8/5 stars. It will use the investment to drive towards Operating Expense (OpEx) profitability by the end of Q1 2021, reach EBITDA positive by the end of 2021, and scale into new markets through remote expansion.
days to go:
Expired
investment:
£5,877,517
An automated platform allowing landlords to manage their properties and save time and money on fees. With brightLET's solution, there is no need for an intermediary person to be involved in the property management process. Landlords can perform administration tasks on their own tenancies, be kept up-to-date on ever-changing regulations and manage tradespeople.
Specific services available to landlords include options to book viewings, upload photos, videos and floorplans, provide reports on inspections, gas safety, EPC, Right 2 Rent and PAT checks. The brightLET platform is available on almost any device, including desktops, tablets and mobile devices.
brightLET has partnered with the YMCA, this has allowed the company access to a provider market and housing association worth more than £10bn. There are various user types utilising the platform, since launch 650+ landlords, 1000+ tenants and 300+ tradespeople are using brightLET to manage their properties.
Their revenue model has resulted in landlords achieving savings on property fees of £450 outside London and £1,368 within London. Funds will primarily be used for growth and expansion within London, as this is where the majority of brightLET landlords are situated. The company aims to increase their brand awareness through marketing campaigns and hire talent to assist with technology developments, sales and customer support.
days to go:
Expired
investment:
£66,932
